The biological pathways of Alzheimer disease: a review

被引:160
作者
Calabro, Marco [1 ]
Rinaldi, Carmela [1 ]
Santoro, Giuseppe [1 ]
Crisafulli, Concetta [1 ]
机构
[1] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy
关键词
Alzheimer disease; biological pathways; immune system; oxidative stress; AMYLOID-BETA-PEPTIDE; GENOME-WIDE ASSOCIATION; BRAIN INSULIN-RESISTANCE; LONG-TERM POTENTIATION; APOLIPOPROTEIN-E; A-BETA; OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; CEREBRAL HYPOPERFUSION; DIAGNOSTIC GUIDELINES;
D O I
10.3934/Neuroscience.2021005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older people, which severely impairs patients' quality of life. In the recent years, the number of affected individuals has seen a rapid increase. It is estimated that up to 107 million subjects will be affected by 2050 worldwide. Research in this area has revealed a lot about the biological and environmental underpinnings of Alzheimer, especially its correlation with beta-Amyloid and Tau related mechanics; however, the precise molecular events and biological pathways behind the disease are yet to be discovered. In this review, we focus our attention on the biological mechanics that may lie behind Alzheimer development. In particular, we briefly describe the genetic elements and discuss about specific biological processes potentially associated with the disease.
引用
收藏
页码:86 / 132
页数:47
相关论文
共 424 条
[101]   The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging [J].
de la Torre, Jack .
JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (01) :35-52
[102]  
de la Torre Jack C, 2012, Cardiovasc Psychiatry Neurol, V2012, P367516, DOI 10.1155/2012/367516
[103]   The secretases: enzymes with therapeutic potential in Alzheimer disease [J].
De Strooper, Bart ;
Vassar, Robert ;
Golde, Todd .
NATURE REVIEWS NEUROLOGY, 2010, 6 (02) :99-107
[104]   Ryanodine receptors: physiological function and deregulation in Alzheimer disease [J].
Del Prete, Dolores ;
Checler, Frederic ;
Chami, Mounia .
MOLECULAR NEURODEGENERATION, 2014, 9
[105]   The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer's disease [J].
Deng, Yu-Lei ;
Liu, Li-Hua ;
Wang, Ying ;
Tang, Hui-Dong ;
Ren, Ru-Jing ;
Xu, Wei ;
Ma, Jian-Fang ;
Wang, Li-Ling ;
Zhuang, Jun-Peng ;
Wang, Gang ;
Chen, Sheng-Di .
HUMAN GENETICS, 2012, 131 (07) :1245-1249
[106]   Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease [J].
Devanand, D. P. .
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2018, 18 (09)
[107]   Protein Homeostasis Networks and the Use of Yeast to Guide Interventions in Alzheimer's Disease [J].
Dhakal, Sudip ;
Macreadie, Ian .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) :1-45
[108]   The Cell Biology of the Unfolded Protein Response [J].
Diehl, J. Alan ;
Fuchs, Serge Y. ;
Koumenis, Costantinos .
GASTROENTEROLOGY, 2011, 141 (01) :38-U109
[109]   Contribution of metabolic syndrome components to cognition in older individuals [J].
Dik, Miranda G. ;
Jonker, Cees ;
Comijs, Hannie C. ;
Deeg, Dorly J. H. ;
Kok, Astrid ;
Yaffe, Kristine ;
Penninx, Brenda W. .
DIABETES CARE, 2007, 30 (10) :2655-2660
[110]   Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse [J].
Dinkins, Michael B. ;
Enasko, John ;
Hernandez, Caterina ;
Wang, Guanghu ;
Kong, Jina ;
Helwa, Inas ;
Liu, Yutao ;
Terry, Alvin V., Jr. ;
Bieberich, Erhard .
JOURNAL OF NEUROSCIENCE, 2016, 36 (33) :8653-8667